Low Infection Rate after Tumor Hip Arthroplasty for Metastatic Bone Disease in a Cohort Treated with Extended Antibiotic Prophylaxis

Background. Compared to conventional hip arthroplasty, endoprosthetic reconstruction after tumor resection is associated with a substantially increased risk of periprosthetic joint infection (PJI), with reported rates of around 10% in a recent systematic review. The optimal duration of antibiotic pr...

Full description

Saved in:
Bibliographic Details
Main Authors: Werner H. Hettwer, Peter Frederik Horstmann, Thea Bechmann Hovgaard, Tomas Andreas Grum-Scwensen, Michael M. Petersen
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Advances in Orthopedics
Online Access:http://dx.doi.org/10.1155/2015/428986
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832549375401787392
author Werner H. Hettwer
Peter Frederik Horstmann
Thea Bechmann Hovgaard
Tomas Andreas Grum-Scwensen
Michael M. Petersen
author_facet Werner H. Hettwer
Peter Frederik Horstmann
Thea Bechmann Hovgaard
Tomas Andreas Grum-Scwensen
Michael M. Petersen
author_sort Werner H. Hettwer
collection DOAJ
description Background. Compared to conventional hip arthroplasty, endoprosthetic reconstruction after tumor resection is associated with a substantially increased risk of periprosthetic joint infection (PJI), with reported rates of around 10% in a recent systematic review. The optimal duration of antibiotic prophylaxis for this patient population remains unknown. Material and Methods. To establish the infection rate associated with prolonged antibiotic prophylaxis in our department, we performed a retrospective review of all adult patients who underwent endoprosthetic reconstruction of the proximal femur after tumor resection for metastatic bone disease during a 4-year period from 2010 to 2013 (n=105 patients). Results. Intravenous antibiotic prophylaxis was administrated for an extended duration of a mean of 7.4 days. The overall infection rate was 3.6% (4/111 implants), infection free survival was 96% at 2 years, and the risk of amputation associated with infection was 25% (1/4 patients). Discussion. Preemptive eradication of bacterial contamination may be of value in certain clinical situations, where the risk level and consequences of implant-associated infection are unacceptable. Our findings suggest that extended postoperative antibiotic prophylaxis may reduce the risk of PJI in patients undergoing tumor resection and endoprosthetic replacement for metastatic bone disease associated impending or de facto pathologic fractures of the proximal femur.
format Article
id doaj-art-516b11e3caac40d9b24a783ae280f012
institution Kabale University
issn 2090-3464
2090-3472
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Advances in Orthopedics
spelling doaj-art-516b11e3caac40d9b24a783ae280f0122025-02-03T06:11:23ZengWileyAdvances in Orthopedics2090-34642090-34722015-01-01201510.1155/2015/428986428986Low Infection Rate after Tumor Hip Arthroplasty for Metastatic Bone Disease in a Cohort Treated with Extended Antibiotic ProphylaxisWerner H. Hettwer0Peter Frederik Horstmann1Thea Bechmann Hovgaard2Tomas Andreas Grum-Scwensen3Michael M. Petersen4Musculoskeletal Tumor Section, Department of Orthopedic Surgery, Rigshospitalet, University of Copenhagen, 2100 Copenhagen, DenmarkMusculoskeletal Tumor Section, Department of Orthopedic Surgery, Rigshospitalet, University of Copenhagen, 2100 Copenhagen, DenmarkMusculoskeletal Tumor Section, Department of Orthopedic Surgery, Rigshospitalet, University of Copenhagen, 2100 Copenhagen, DenmarkMusculoskeletal Tumor Section, Department of Orthopedic Surgery, Rigshospitalet, University of Copenhagen, 2100 Copenhagen, DenmarkMusculoskeletal Tumor Section, Department of Orthopedic Surgery, Rigshospitalet, University of Copenhagen, 2100 Copenhagen, DenmarkBackground. Compared to conventional hip arthroplasty, endoprosthetic reconstruction after tumor resection is associated with a substantially increased risk of periprosthetic joint infection (PJI), with reported rates of around 10% in a recent systematic review. The optimal duration of antibiotic prophylaxis for this patient population remains unknown. Material and Methods. To establish the infection rate associated with prolonged antibiotic prophylaxis in our department, we performed a retrospective review of all adult patients who underwent endoprosthetic reconstruction of the proximal femur after tumor resection for metastatic bone disease during a 4-year period from 2010 to 2013 (n=105 patients). Results. Intravenous antibiotic prophylaxis was administrated for an extended duration of a mean of 7.4 days. The overall infection rate was 3.6% (4/111 implants), infection free survival was 96% at 2 years, and the risk of amputation associated with infection was 25% (1/4 patients). Discussion. Preemptive eradication of bacterial contamination may be of value in certain clinical situations, where the risk level and consequences of implant-associated infection are unacceptable. Our findings suggest that extended postoperative antibiotic prophylaxis may reduce the risk of PJI in patients undergoing tumor resection and endoprosthetic replacement for metastatic bone disease associated impending or de facto pathologic fractures of the proximal femur.http://dx.doi.org/10.1155/2015/428986
spellingShingle Werner H. Hettwer
Peter Frederik Horstmann
Thea Bechmann Hovgaard
Tomas Andreas Grum-Scwensen
Michael M. Petersen
Low Infection Rate after Tumor Hip Arthroplasty for Metastatic Bone Disease in a Cohort Treated with Extended Antibiotic Prophylaxis
Advances in Orthopedics
title Low Infection Rate after Tumor Hip Arthroplasty for Metastatic Bone Disease in a Cohort Treated with Extended Antibiotic Prophylaxis
title_full Low Infection Rate after Tumor Hip Arthroplasty for Metastatic Bone Disease in a Cohort Treated with Extended Antibiotic Prophylaxis
title_fullStr Low Infection Rate after Tumor Hip Arthroplasty for Metastatic Bone Disease in a Cohort Treated with Extended Antibiotic Prophylaxis
title_full_unstemmed Low Infection Rate after Tumor Hip Arthroplasty for Metastatic Bone Disease in a Cohort Treated with Extended Antibiotic Prophylaxis
title_short Low Infection Rate after Tumor Hip Arthroplasty for Metastatic Bone Disease in a Cohort Treated with Extended Antibiotic Prophylaxis
title_sort low infection rate after tumor hip arthroplasty for metastatic bone disease in a cohort treated with extended antibiotic prophylaxis
url http://dx.doi.org/10.1155/2015/428986
work_keys_str_mv AT wernerhhettwer lowinfectionrateaftertumorhiparthroplastyformetastaticbonediseaseinacohorttreatedwithextendedantibioticprophylaxis
AT peterfrederikhorstmann lowinfectionrateaftertumorhiparthroplastyformetastaticbonediseaseinacohorttreatedwithextendedantibioticprophylaxis
AT theabechmannhovgaard lowinfectionrateaftertumorhiparthroplastyformetastaticbonediseaseinacohorttreatedwithextendedantibioticprophylaxis
AT tomasandreasgrumscwensen lowinfectionrateaftertumorhiparthroplastyformetastaticbonediseaseinacohorttreatedwithextendedantibioticprophylaxis
AT michaelmpetersen lowinfectionrateaftertumorhiparthroplastyformetastaticbonediseaseinacohorttreatedwithextendedantibioticprophylaxis